G40
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Pharmacoresistant focal epilepsy - Pre-surgical video-EEG monitoring planned (prospective cohort) or performed in the years 2010-2024 (historical cohort) - Average of at least 3 seizures per 3 months (prospective cohort) - Average of at least 3 seizure-free weeks per 3 months (prospective cohort)
Exclusion criteria
Exclusion criteria: - Reliable outpatient seizure documentation not possible (prospective cohort) - Reliable wearing of a smartwatch for >22 hours a day not possible (prospective cohort) - Lack of capacity to consent (prospective cohort)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of epileptic seizures per VEM day | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of VEM; Percentage reduction in cumulative ASM daily dose during VEM compared to daily dose at admission; Diagnostic need for repeated VEM | — |
Countries
Germany
Contacts
Charité - Universitätsmedizin Berlin